MENU
GRCE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Grace Therapeutics (GRCE) Ownership - Who owns Grace Therapeutics?
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
31.69M
P/E Ratio
N/A
Total Cash
11.06M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
0.81
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
GRCE
Capitalization
31.7M
P/E Ratio
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash
11.1M
Total Cash/Share
0.81
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
52.1M
P/B Ratio
0.61
Cash Flow
N/A
Earnings
-1.53
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
6.06
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-16.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.46
Shares Held By Institutions
7.85M
Shares Outstanding - Current
13.7M
Total Liabilities
9.09M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-38.235
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of Pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A